Sylvain Landry Faye
Cheikh Anta Diop University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Sylvain Landry Faye.
PLOS Medicine | 2016
Badara Cisse; El Hadj Ba; Cheikh Sokhna; Jean Louis Ndiaye; Jules F. Gomis; Yankhoba Dial; Catherine Pitt; M. Ndiaye; Matthew Cairns; Ernest Faye; Magatte Ndiaye; Aminata Lo; Roger Tine; Sylvain Landry Faye; Babacar Faye; Ousmane Sy; Lansana Konate; Ekoue Kouevijdin; Clare Flach; Ousmane Faye; Jean-François Trape; Colin J. Sutherland; Fatou Ba Fall; Pape M. Thior; Oumar Faye; Brian Greenwood; Oumar Gaye; Paul Milligan
Background Seasonal Malaria Chemoprevention (SMC) with sulfadoxine-pyrimethamine (SP) plus amodiaquine (AQ), given each month during the transmission season, is recommended for children living in areas of the Sahel where malaria transmission is highly seasonal. The recommendation for SMC is currently limited to children under five years of age, but, in many areas of seasonal transmission, the burden in older children may justify extending this age limit. This study was done to determine the effectiveness of SMC in Senegalese children up to ten years of age. Methods and Findings SMC was introduced into three districts over three years in central Senegal using a stepped-wedge cluster-randomised design. A census of the population was undertaken and a surveillance system was established to record all deaths and to record all cases of malaria seen at health facilities. A pharmacovigilance system was put in place to detect adverse drug reactions. Fifty-four health posts were randomised. Nine started implementation of SMC in 2008, 18 in 2009, and a further 18 in 2010, with 9 remaining as controls. In the first year of implementation, SMC was delivered to children aged 3–59 months; the age range was then extended for the latter two years of the study to include children up to 10 years of age. Cluster sample surveys at the end of each transmission season were done to measure coverage of SMC and the prevalence of parasitaemia and anaemia, to monitor molecular markers of drug resistance, and to measure insecticide-treated net (ITN) use. Entomological monitoring and assessment of costs of delivery in each health post and of community attitudes to SMC were also undertaken. About 780,000 treatments were administered over three years. Coverage exceeded 80% each month. Mortality, the primary endpoint, was similar in SMC and control areas (4.6 and 4.5 per 1000 respectively in children under 5 years and 1.3 and 1.2 per 1000 in children 5-9 years of age; the overall mortality rate ratio [SMC: no SMC] was 0.90, 95% CI 0.68–1.2, p = 0.496). A reduction of 60% (95% CI 54%–64%, p < 0.001) in the incidence of malaria cases confirmed by a rapid diagnostic test (RDT) and a reduction of 69% (95% CI 65%–72%, p < 0.001) in the number of treatments for malaria (confirmed and unconfirmed) was observed in children. In areas where SMC was implemented, incidence of confirmed malaria in adults and in children too old to receive SMC was reduced by 26% (95% CI 18%–33%, p < 0.001) and the total number of treatments for malaria (confirmed and unconfirmed) in these older age groups was reduced by 29% (95% CI 21%–35%, p < 0.001). One hundred and twenty-three children were admitted to hospital with a diagnosis of severe malaria, with 64 in control areas and 59 in SMC areas, showing a reduction in the incidence rate of severe disease of 45% (95% CI 5%–68%, p = 0.031). Estimates of the reduction in the prevalence of parasitaemia at the end of the transmission season in SMC areas were 68% (95% CI 35%–85%) p = 0.002 in 2008, 84% (95% CI 58%–94%, p < 0.001) in 2009, and 30% (95% CI -130%–79%, p = 0.56) in 2010. SMC was well tolerated with no serious adverse reactions attributable to SMC drugs. Vomiting was the most commonly reported mild adverse event but was reported in less than 1% of treatments. The average cost of delivery was US
Malaria Journal | 2013
Youssoupha Ndiaye; Jean La Ndiaye; Badara Cisse; Demetri Blanas; Jonas Bassene; Isaac Manga; Mansour Ndiath; Sylvain Landry Faye; Mamoudou Bocoum; M. Ndiaye; Pape M. Thior; Doudou Sene; Paul Milligan; Omar Gaye; David Schellenberg
0.50 per child per month, but varied widely depending on the size of the health post. Limitations included the low rate of mortality, which limited our ability to detect an effect on this endpoint. Conclusions SMC substantially reduced the incidence of outpatient cases of malaria and of severe malaria in children, but no difference in all-cause mortality was observed. Introduction of SMC was associated with an overall reduction in malaria incidence in untreated age groups. In many areas of Africa with seasonal malaria, there is a substantial burden in older children that could be prevented by SMC. SMC in older children is well tolerated and effective and can contribute to reducing malaria transmission. Trial Registration ClinicalTrials.gov NCT00712374
Malaria Journal | 2013
Dana Loll; Sara Berthe; Sylvain Landry Faye; Issa Wone; Hannah Koenker; Bethany Arnold; Rachel Weber
BackgroundDespite recent advances in malaria diagnosis and treatment, many isolated communities in rural settings continue to lack access to these life-saving tools. Community-case management of malaria (CCMm), consisting of lay health workers (LHWs) using malaria rapid diagnostic tests (RDTs) and artemisinin-based combination therapy (ACT) in their villages, can address this disparity.MethodsThis study examined routine reporting data from a CCMm programme between 2008 and 2011 in Saraya, a rural district in Senegal, and assessed its impact on timely access to rapid diagnostic tests and ACT.ResultsThere was a seven-fold increase in the number of LHWs providing care and in the number of patients seen. LHW engagement in the CCM programme varied seasonally, 24,3% of all patients prescribed an ACT had a negative RDT or were never administered an RDT, and less than half of patients with absolute indications for referral (severe symptoms, age under two months and pregnancy) were referred. There were few stock-outs.DiscussionThis CCMm programme successfully increased the number of patients with access to RDT and ACT, but further investigation is required to identify the cause for over-prescription, and low rates of referrals for patients with absolute indications. In contrast, previous widespread stock-outs in Saraya’s CCMm programme have now been resolved.ConclusionThis study demonstrates the potential for CCMm programmes to substantially increase access to life-saving malarial diagnostics and treatment, but also highlights important challenges in ensuring quality.
Malaria Journal | 2014
Sara Berthe; Dana Loll; Sylvain Landry Faye; Issa Wone; Hannah Koenker; Bethany Arnold; Rachel Weber
BackgroundProcurement and distribution of long-lasting insecticidal nets (LLINs) in the African region has decreased from 145 million in 2010 to 66 million nets in 2012. As resources for LLIN distribution appear to stagnate, it is important to understand the users’ perception of the life span of a net and at what point and why they stop using it. In order to get the most value out of distributed nets and to ensure that they are used for as long as possible, programmes must communicate to users about how to assess useful net life and how to extend it.MethodsData were collected from 114 respondents who participated in 56 in-depth interviews (IDIs) and eight focus group discussions (FGDs) in August 2012 in eight regions in Senegal. Households were eligible for the study if they owned at least one net and had an available household member over the age of 18. Data were coded by a team of four coders in ATLAS.ti using a primarily deductive approach.ResultsRespondents reported assessing useful net life using the following criteria: the age of net, the number and size of holes and the presence of mosquitoes in the net at night. If they had the means to do so, many respondents preferred the acquisition of a new net rather than the continued use of a very torn net. However, respondents would preferentially use newer nets, saving older, but useable nets for the future or sharing them with family or friends. Participants reported observing alternative uses of nets, primarily for nets that were considered expired.ConclusionsThe results indicate that decisions regarding the end of net life vary among community members in Senegal, but are primarily related to net integrity. Additional research is needed into user-determined end of net life as well as care and repair behaviours, which could extend useful net life. The results from this study and from future research on this topic should be used to understand current behaviours and develop communication programmes to prolong the useful life of nets.
Vaccine | 2017
Nathan Peiffer-Smadja; Ramatou Ouedraogo; Eric D'Ortenzio; Papa Ndiaga Cissé; Zahra Zeggani; Abdoul Habib Beavogui; Sylvain Landry Faye; Frédéric Le Marcis; Yazdan Yazdanpanah; Vinh-Kim Nguyen
BackgroundDespite recent advances in the fight against the disease, malaria remains a serious threat to the health and well-being of populations in endemic countries. The use of long-lasting insecticidal nets (LLIN) reduces contact between the vector and humans, thereby reducing transmission of the disease. LLINs have become an essential component of malaria control programmes worldwide.MethodsThe Culture of Net Use study used qualitative and quantitative methods in a longitudinal and iterative design over two phases, in order to capture changes in net use over a year and a half period and covering both dry and rainy seasons. Data were collected from a total of 56 households in eight regions to understand variations due to geographical, cultural, and universal coverage differences. At the time of the data collection, the universal coverage campaign had been completed in six of the eight regions (Dakar and Thies excluded).ResultsPerceived barriers to use were primarily related to the characteristics of the net itself, include shape, insecticide, and a variety of minority responses, such as perceived lack of mosquito density and being unaccustomed to using nets. Insecticide-related complaints found that insecticide did not present a significant barrier to use, but was cited as a nuisance. Feelings of suffocation continued to be the most commonly cited nuisance. Respondents who favoured the use of insecticide on nets appeared to be more aware of the health and malaria prevention benefits of the insecticide than those who perceived it negatively.ConclusionDespite prior evidence that barriers such as heat, shape, insecticide and perceived mosquito density contribute to non-use of LLINs in other countries, this study has shown that these factors are considered more as nuisances and that they do not consistently prevent the use of nets among respondents in Senegal. Of those who cited inconveniences with their nets, few were moved to stop using a net. Respondents from this study overcame these barriers and continue to value the importance of nets.
Scientific Reports | 2018
El-Hadj Bâ; Catherine Pitt; Yankhoba Dial; Sylvain Landry Faye; Matthew Cairns; Ernest Faye; M. Ndiaye; Jules-Francois Gomis; Babacar Faye; Jean Louis Ndiaye; Cheikh Sokhna; Oumar Gaye; Badara Cisse; Paul Milligan
INTRODUCTION There are few data on the acceptability of vaccination or blood sampling during Ramadan fasting month in Muslim countries. This could impact vaccination campaigns, clinical trials or healthcare during Ramadan. METHODS Using a semi-structured questionnaire, we conducted a cross-sectional study on 201 practising Muslims and 10 religious leaders in Conakry, Guinea in the wake of the recent epidemic Ebola epidemic. Acceptability of vaccination and blood sampling during Ramadan were investigated as well as reasons for refusal. RESULTS Vaccination was judged acceptable during Ramadan by 46% (93/201, 95% CI 0.40-0.53) of practising Muslims versus 80% (8/10, 95% CI 0.49-0.94) of religious leaders (p=0.11). Blood sampling was judged acceptable during Ramadan by 54% (108/201, 95% CI 0.47-0.60) of practising Muslims versus 80% (8/10, 95% CI 0.49-0.94) of religious leaders (p=0.19). The percentage of participants that judged both blood sampling and vaccination acceptable during Ramadan was 40% (81/201, 95% CI 0.34-0.47) for practising Muslims versus 80% (8/10, 95% CI 0.49-0.94) for religious leaders (p=0.048). The most common reasons for refusal of vaccination or blood sampling were that nothing should enter or leave the body during Ramadan (43%), that adverse events could lead to breaking the fast (32%), that blood should not be seen during Ramadan (9%) and that the Quran explicitly forbids it (9%). DISCUSSION Although most Muslims leaders and scientists consider that injections including immunization and blood sampling should be authorized during Ramadan, many Muslims in our study judged vaccination or blood sampling unacceptable when fasting. Widely available recommendations on healthcare during Ramadan would be useful to inform Muslims.
Scientific Reports | 2018
El-Hadj Bâ; Catherine Pitt; Yankhoba Dial; Sylvain Landry Faye; Matthew Cairns; Ernest Faye; M. Ndiaye; Jules-Francois Gomis; Babacar Faye; Jean Louis Ndiaye; Cheikh Sokhna; Oumar Gaye; Badara Cisse; Paul Milligan
SMC has been introduced widely in the Sahel since its recommendation by WHO in 2012. This study, which provided evidence of feasibility that supported the recommendation, included school-age and pre-school children. School-age children were not included in the 2012 recommendation but bear an increasing proportion of cases. In 2006, consultations with health-staff were held to choose delivery methods. The preferred approach, door-to-door with the first daily-dose supervised by a community-health-worker (CHW), was piloted and subsequently evaluated on a large-scale in under-5’s in 2008 and then in under-10’s 2009–2010. Coverage was higher among school-age children (96%(95%CI 94%,98%) received three treatments in 2010) than among under 5’s (90%(86%,94%)). SMC was more equitable than LLINs (odds-ratio for increase in coverage for a one-level rise in socioeconomic-ranking (a 5-point scale), was 1.1 (0.95,1.2) in 2009, compared with OR 1.3 (1.2,1.5) for sleeping under an LLIN. Effective communication was important in achieving high levels of uptake. Continued training and supervision were needed to ensure CHWs adhered to treatment guidelines. SMC door-to-door can, if carefully supervised, achieve high equitable coverage and high-quality delivery. SMC programmes can be adapted to include school-age children, a neglected group that bears a substantial burden of malaria.
BMJ Global Health | 2018
Janice E. Graham; Shelley Lees; Frédéric Le Marcis; Sylvain Landry Faye; Robert Lorway; Maya Ronse; Sharon Abramowitz; Koen Peeters Grietens
A correction to this article has been published and is linked from the HTML and PDF versions of this paper. The error has not been fixed in the paper.
Global Health Promotion | 2013
Sylvain Landry Faye; Frédéric Le Marcis; Fatoumata Bintou Samb; Mouhamed Badji
### Summary box How prepared were we for this most recent Ebola outbreak? Real-time emergent research is imperative for successful response to global health emergencies. While innovative biomedical interventions are certainly important,1 local on-the-ground realities during the 2014–2015 West African Ebola epidemic demanded a different though complementary set of research skills. Effective response required deep, sensitive understandings of emergent local dynamics and flexible, emergent solution. Emergency intervention called for evolving, flexible emergent methods that produced and translated rapid knowledge throughout the crisis. Yet, the need for emergent theory methodologies such as ethnography that actively witness and document the unforeseen consequences of emergencies and their response receives little attention in preparedness strategies.2 Global health community preparedness and response largely hinges on the rapid financialisation and development of innovative …
Malaria Journal | 2014
Dana Loll; Sara Berthe; Sylvain Landry Faye; Issa Wone; Bethany Arnold; Hannah Koenker; Joan Schubert; Youssoufa Lo; Julie Thwing; Ousmane Faye; Rachel Weber
Cet article analyse, à partir d’une ethnographie menée à Oussouye (Casamance), la manière dont s’incarnent et se traduisent les politiques nationales sanitaires, dans des contextes locaux spécifiques. Il discute des contraintes que rencontre une politique globalisante, ou plus exactement des points aveugles de cette politique pas suffisamment à l’écoute du contexte, c’est-à-dire, des spécificités régionales et géopolitiques. Les résultats indiquent que le contexte de la décentralisation et du conflit casamançais ont eu des effets sur le financement, la gestion des activités promotionnelles et la domestication des recommandations officielles de la lutte contre le paludisme. Par ailleurs, celles antérieures laissent des traces, qui s’expriment dans les discours des acteurs et structurent la façon dont ils pensent la lutte aujourd’hui, alors même que cette dernière est supposée s’inscrire dans un autre paradigme. Enfin la dissonance de la prescription d’antipaludiques à Mlomp et Elinkine fait penser à l’existence de « territoires » locaux de la santé où les recommandations nationales cèdent la place aux spécificités contextuelles et locales. Les politiques de santé ne peuvent faire l’économie ni des acteurs, ni des contextes locaux, cependant la prise en compte de la spécificité ne doit certainement pas se faire au détriment d’une certaine notion de « l’être ensemble ».